Global Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Anticipated to Expand Rapidly From 2025 to 2029

 Use Code ONLINE20 to Save 20% On Global Market Reports — Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics

 

 What Are the Key Growth Indicators and Market Expansion Estimates for the Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Through 2029?
 The real-time blood glucose continuous glucose monitoring (CGM) patch market size has grown rapidly in recent years. It will grow from $6.12 billion in 2024 to $7.04 billion in 2025 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to broader reimbursement coverage, strong clinical evidence base, clinician training and familiarity, shift toward home-based chronic care, and endorsement in professional guidelines.
 
 The real-time blood glucose continuous glucose monitoring (CGM) patch market size is expected to see rapid growth in the next few years. It will grow to $12.14 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to increasing prediabetes screening and earlier diagnosis, expanded coverage for insulin and non-insulin users, value-based care incentives linked to time in range outcomes, aging populations with higher metabolic disease burden, and urbanization and dietary transitions in emerging economies. Major trends in the forecast period include extended-wear patch sensors beyond two weeks, automated insulin delivery integration with patch-based continuous glucose monitoring, direct-to-watch connectivity without smartphone reliance, on-body vibration and discreet alert innovations, and advanced biocompatible adhesives reducing skin irritation.
 
 Get your free report sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=29166&type=smp
 
 Which Key Drivers Are Fueling Growth in the Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?
 The rising prevalence of diabetes is expected to propel the growth of the real-time blood glucose continuous glucose monitoring (CGM) patch market going forward. Diabetes refers to a chronic metabolic disorder characterized by elevated blood glucose levels due to insufficient insulin production or insulin resistance. The prevalence of diabetes is rising because increasing obesity leads to higher insulin resistance, which disrupts blood sugar regulation and significantly elevates the risk of developing type 2 diabetes. Real-time blood glucose continuous glucose monitoring (CGM) patch enables people with diabetes to continuously track their blood glucose levels in real time, providing timely alerts for hyperglycemia or hypoglycemia, helping them make informed dietary, medication, and lifestyle adjustments, and ultimately improving overall disease management and reducing the risk of complications. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, rising prevalence of diabetes is driving the growth of the real-time blood glucose continuous glucose monitoring (CGM) patch market.
 
 How Is the Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Categorized Based on Key Segments?
 The real-time blood glucose continuous glucose monitoring (cgm) patchmarket covered in this report is segmented — 
 
 1) By Product Type: Wearable Continuous Glucose Monitoring (CGM) Patch, Implantable Continuous Glucose Monitoring (CGM) Patch
 2) By Technology: Enzymatic, Non-Enzymatic
 3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels
 4) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Other Applications
 5) By End User: Hospitals And Clinics, Homecare Settings, Diagnostic Centers, Other End Users
 
 Subsegments:
 1) By Wearable Continuous Glucose Monitoring (CGM) Patch: Sensor-Embedded Wearable Continuous Glucose Monitoring (CGM) Patch, Bluetooth-Enabled Wearable Continuous Glucose Monitoring (CGM) Patch, Mobile-Connected Wearable Continuous Glucose Monitoring (CGM) Patch, Telehealth-Compatible Wearable Continuous Glucose Monitoring (CGM) Patch
 2) By Implantable Continuous Glucose Monitoring (CGM) Patch: Subcutaneous Implantable Continuous Glucose Monitoring (CGM) Patch, Long-Term Implantable Continuous Glucose Monitoring (CGM) Patch, Miniaturized Implantable Continuous Glucose Monitoring (CGM) Patch, Remote-Monitoring Implantable Continuous Glucose Monitoring (CGM) Patch
 
 What Are the Most Prominent Trends Impacting the Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?
 Major companies operating in the real-time blood glucose continuous glucose monitoring (CGM) patch market are focusing on developing innovative products such as over-the-counter continuous glucose monitoring sensors to expand access and improve user convenience. Over-the-counter continuous glucose monitoring (CGM) sensors are wearable devices that track glucose levels in real time and can be purchased without a prescription, helping users monitor their glucose continuously, understand how lifestyle factors affect their levels, and manage or prevent diabetes more easily. For instance, in September 2024, Dexcom Inc., a US-based diabetes technology company, launched Stelo, its first over-the-counter (OTC) continuous glucose monitoring (CGM) patch in the United States. The small, wearable sensor is applied to the back of the upper arm and provides real-time glucose readings directly to a smartphone app without the need for fingersticks. This is designed for people with Type 2 diabetes not using insulin and those with prediabetes, Stelo delivers personalized insights on how diet, exercise, and sleep affect glucose levels. The device features up to 15-day wear time, waterproofing, spike and pattern detection, and integrates with Dexcom’s proven glucose sensing technology, making continuous glucose monitoring more accessible, convenient, and actionable for a broader population.
 
 Who Are the Leading Market Participants in the Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?
 Major companies operating in the real-time blood glucose continuous glucose monitoring (CGM) patch market are F. Hoffmann-La Roche AG, Abbott Laboratories, Medtronic plc, Dexcom Inc., Trinity Biotech plc, Biolinq Inc., Ascensia Diabetes Care Holdings AG, Senseonics Holdings Inc., A. Menarini Diagnostics S.r.l., RSP Systems A/S, OrSense Ltd., Rockley Photonics Holdings Ltd., Sinocare Inc., CNOGA Medical Ltd., Medtrum Technologies Inc., Nutromics Ltd., Nemaura Medical Inc., DiaMonTech GmbH, Movano Health Inc., and GlucoRx Ltd.
 
 Get the detailed real-time blood glucose continuous glucose monitoring (cgm) patch market report today
 https://www.thebusinessresearchcompany.com/report/real-time-blood-glucose-continuous-glucose-monitoring-cgm-patch-global-market-report
 
 Which Regions Are Driving the Highest Demand in the Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?
 North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time blood glucose continuous glucose monitoring (CGM) patch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company